Other Species / Isoforms
  p300 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S12-p
VVEPGPPsAkRPKLs
Upstream
Downstream
2 6
Effects on Modified Protein
  • acetylation
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • cell differentiation, induced
  • signaling pathway regulation
  • transcription, induced
Putative in vivo kinases:
  • P38B (human)
Regulatory protein:
  • P38A (human)
  • TLR4 (human)
Treatment
  • conditioned medium
  • nilotinib
  • SB202190
  • siRNA
view more >
p300 (human) VVEPGPPsAkRPKLs S12-p
p300 (mouse) VVEPGPPsAKRPKLS S12-p
p300 (rat) VVEPGPPSAKRPKLS S12
K14-ac
EPGPPsAkRPKLsSP
0 1
p300 (human) EPGPPsAkRPKLsSP K14-ac
p300 (mouse) EPGPPsAKRPKLSSP K14
p300 (rat) EPGPPSAKRPKLSSP K14
S19-p
sAkRPKLsSPALSAS
1 1
p300 (human) sAkRPKLsSPALSAS S19-p
p300 (mouse) sAKRPKLSSPALSAS S19
p300 (rat) SAKRPKLSSPALSAS S19
K77-ac
MVQDAASkHkQLSEL
1 0
p300 (human) MVQDAASkHkQLSEL K77-ac
p300 (mouse) IVQDAASKHKQLSEL K77
p300 (rat) IVQDAASKHkQLSEL K77
K79-ac
QDAASkHkQLSELLR
1 1
p300 (human) QDAASkHkQLSELLR K79-ac
p300 (mouse) QDAASKHKQLSELLR K79
p300 (rat) QDAASKHkQLSELLR K79-ac
S89-p
SELLRSGsSPNLNMG
Upstream
Downstream
14 2
Effects on Modified Protein
  • acetylation
  • enzymatic activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell motility, induced
  • transcription, induced
  • transcription, inhibited
Kinase, in vitro:
  • AMPKA1 (human)
  • PKCD (human)
  • RSK4 (human)
view more >
Putative in vivo kinases:
  • AMPKA1 (human)
  • AMPKA2 (human)
  • PKCA (human)
  • PKCD (human)
  • PKCI (human)
  • RSK4 (human)
view more >
Putative upstream phosphatases:
  • PPP2CA (human)
Regulatory protein:
  • AMPKA1 (human)
Treatment
  • A769662
  • acadesine
  • amino_acid_starvation
  • calphostin_C
  • cantharidin
  • compound_C
  • ghrelin
  • Go_6976
  • metformin
  • phenylephrine
  • phorbol_ester
  • Ro31-8220
  • rottlerin
  • siRNA
  • TPO
view more >
p300 (human) SELLRSGsSPNLNMG S89-p
p300 (mouse) SELLRSGsSPNLNMG S89-p
p300 (rat) SELLRSGSSPNLNMG S89
S106-p
GPGQVMAsQAQQSSP
Upstream
Downstream
3 0
Effects on Modified Protein
  • acetylation
  • enzymatic activity, induced
  • molecular association, regulation
  • protein stabilization
Kinase, in vitro:
  • ATM (human)
Putative in vivo kinases:
  • ATM (human)
Treatment
  • etoposide
  • ionizing_radiation
p300 (human) GPGQVMAsQAQQSSP S106-p
p300 (mouse) GPGQAMASQAQQNsP S106
p300 (rat) GPGQVMASQAQQNSP S106
S112
AsQAQQSSPGLGLIN
0 1
p300 (human) AsQAQQSSPGLGLIN S112
p300 (mouse) ASQAQQNsPGLsLIN S112-p
p300 (rat) ASQAQQNSPGLSLIN S112
G116
QQSSPGLGLINSMVK
0 1
p300 (human) QQSSPGLGLINSMVK G116
p300 (mouse) QQNsPGLsLINsMVK S116-p
p300 (rat) QQNSPGLSLINSMVK S116
S120
PGLGLINSMVKSPMT
0 1
p300 (human) PGLGLINSMVKSPMT S120
p300 (mouse) PGLsLINsMVKSPMA S120-p
p300 (rat) PGLSLINSMVKSPMA S120
R200-m1
NGSIGAGrGRQNMQY
0 1
p300 (human) NGSIGAGrGRQNMQY R200-m1
p300 (mouse) NGSIGAGRGRPNMQY R201
p300 (rat) NGSIGAGRGRPNMQY R201
R237-m1
MGGQTGLrGPQPLkM
0 3
p300 (human) MGGQTGLrGPQPLkM R237-m1
p300 (mouse) MGGQPGLRGPQPLKM R238
p300 (rat) MGGQPGLRGPQSHKM R238
K243-m1
LrGPQPLkMGMMNNP
0 1
p300 (human) LrGPQPLkMGMMNNP K243-m1
p300 (mouse) LRGPQPLKMGMMNNP K244
p300 (rat) LRGPQSHKMGMMSNP K244
S285-p
TVLSNNLsPFAMDkk
Upstream
0 17
Treatment
  • ischemia
p300 (human) TVLSNNLsPFAMDkk S285-p
p300 (mouse) TVLPNNLsPFAMDKK S286-p
p300 (rat) TVLPNNLSPFAMDkK S286
K291-ac
LsPFAMDkkAVPGGG
1 19
p300 (human) LsPFAMDkkAVPGGG K291-ac
p300 (mouse) LsPFAMDKKAVPGGG K292
p300 (rat) LSPFAMDkKAVTGGG K292-ac
K292-ac
sPFAMDkkAVPGGGM
1 2
p300 (human) sPFAMDkkAVPGGGM K292-ac
p300 (mouse) sPFAMDKKAVPGGGM K293
p300 (rat) SPFAMDkKAVTGGGM K293
T317-p
VQQPGLVtPVAQGMG
Upstream
1 0
Kinase, in vitro:
  • ERK2 (human)
p300 (human) VQQPGLVtPVAQGMG T317-p
p300 (mouse) VQQPGLVTPVAAGMG T318
p300 (rat) VQQPGLVNPVAPGMG N318
K336-ac
TADPEKRkLIQQQLV
1 0
p300 (human) TADPEKRkLIQQQLV K336-ac
p300 (mouse) TADPEKRKLIQQQLV K337
p300 (rat) TADPEKRKLIQQQLV K337
K350-ac
VLLLHAHkCQRREQA
1 2
p300 (human) VLLLHAHkCQRREQA K350-ac
p300 (mouse) VLLLHAHKCQRREQA K351
p300 (rat) VLLLHAHKCQRREQA K351
K373-ac
LPHCRTMkNVLNHMT
1 4
p300 (human) LPHCRTMkNVLNHMT K373-ac
p300 (mouse) LPHCRTMKNVLNHMT K374
p300 (rat) LPHCRTMKNVLNHMT K374
K373-ub
LPHCRTMkNVLNHMT
0 1
p300 (human) LPHCRTMkNVLNHMT K373-ub
p300 (mouse) LPHCRTMKNVLNHMT K374
p300 (rat) LPHCRTMKNVLNHMT K374
K386-ac
MTHCQSGkSCQVAHC
1 4
p300 (human) MTHCQSGkSCQVAHC K386-ac
p300 (mouse) MTHCQSGKSCQVAHC K387
p300 (rat) MTHCQSGKSCQVAHC K387
K404-ac
RQIISHWkNCTRHDC
1 0
p300 (human) RQIISHWkNCTRHDC K404-ac
p300 (mouse) RQIISHWKNCTRHDC K405
p300 (rat) RQIISHWKNCTRHDC K405
K418-ac
CPVCLPLkNAGDkRN
1 6
p300 (human) CPVCLPLkNAGDkRN K418-ac
p300 (mouse) CPVCLPLKNAGDKRN K419
p300 (rat) CPVCLPLKNAGDKRN K419
K423-ac
PLkNAGDkRNQQPIL
1 10
p300 (human) PLkNAGDkRNQQPIL K423-ac
p300 (mouse) PLKNAGDKRNQQSIL K424
p300 (rat) PLKNAGDKRNQQSIL K424
K489-ac
TQPQVQAkNQQNQQP
Upstream
1 1
Regulatory protein:
  • SIRT1 (human)
Treatment
  • resveratrol
p300 (human) TQPQVQAkNQQNQQP K489-ac
p300 (mouse) PQPQVQAKNQQSQPS K490
p300 (rat) PQPPVQAKNQQSQPS K490
S499-p
QNQQPGQsPQGMRPM
0 7
p300 (human) QNQQPGQsPQGMRPM S499-p
p300 (mouse) QSQPSGQsPQGMRSV S500-p
p300 (rat) QSQPSGQSPQGMRSM S500
K569-ac
PSTTGIRkQWHEDIT
1 0
p300 (human) PSTTGIRkQWHEDIT K569-ac
p300 (mouse) PSSTGIRKQWHEDIT K570
p300 (rat) PSSTGIRKQWHEDIT K570
K569-ub
PSTTGIRkQWHEDIT
0 1
p300 (human) PSTTGIRkQWHEDIT K569-ub
p300 (mouse) PSSTGIRKQWHEDIT K570
p300 (rat) PSSTGIRKQWHEDIT K570
K601-ac
TPDPAALkDRRMENL
1 2
p300 (human) TPDPAALkDRRMENL K601-ac
p300 (mouse) TPDPAALKDRRMENL K602
p300 (rat) TPDPAALKDRRMENL K602
Y611-p
RMENLVAyARkVEGD
Upstream
0 3
Treatment
  • gefitinib
p300 (human) RMENLVAyARkVEGD Y611-p
p300 (mouse) RMENLVAyARKVEGD Y612-p
p300 (rat) RMENLVAYARKVEGD Y612
K614-ac
NLVAyARkVEGDMyE
1 0
p300 (human) NLVAyARkVEGDMyE K614-ac
p300 (mouse) NLVAyARKVEGDMYE K615
p300 (rat) NLVAYARKVEGDMYE K615
K614-ub
NLVAyARkVEGDMyE
0 1
p300 (human) NLVAyARkVEGDMyE K614-ub
p300 (mouse) NLVAyARKVEGDMYE K615
p300 (rat) NLVAYARKVEGDMYE K615
Y620-p
RkVEGDMyESANNRA
Upstream
0 2
Treatment
  • gefitinib
p300 (human) RkVEGDMyESANNRA Y620-p
p300 (mouse) RKVEGDMYESANNRA Y621
p300 (rat) RKVEGDMYESANNRA Y621
Y629-p
SANNRAEyyHLLAEk
0 2
p300 (human) SANNRAEyyHLLAEk Y629-p
p300 (mouse) SANNRAEYYHLLAEK Y630
p300 (rat) SANNRAEyYHLLAEK Y630-p
Y630-p
ANNRAEyyHLLAEkI
0 1
p300 (human) ANNRAEyyHLLAEkI Y630-p
p300 (mouse) ANNRAEYYHLLAEKI Y631
p300 (rat) ANNRAEyYHLLAEKI Y631
K636-ac
yyHLLAEkIYKIQKE
Upstream
1 9
Treatment
  • MS275
p300 (human) yyHLLAEkIYKIQKE K636-ac
p300 (mouse) YYHLLAEKIYKIQKE K637
p300 (rat) yYHLLAEKIYKIQKE K637
K636-ub
yyHLLAEkIYKIQKE
0 1
p300 (human) yyHLLAEkIYKIQKE K636-ub
p300 (mouse) YYHLLAEKIYKIQKE K637
p300 (rat) yYHLLAEKIYKIQKE K637
R705-m1
VPNQMMPrITPQSGL
0 1
p300 (human) VPNQMMPrITPQSGL R705-m1
p300 (mouse) VPNHMMPRMTPQPGL R706
p300 (rat) VPNQMMPRMTPQPGL R706
R728-m1
AQPPIVPrQTPPLQH
0 3
p300 (human) AQPPIVPrQTPPLQH R728-m1
p300 (mouse) PQPPIGPRQPSPLQH R729
p300 (rat) gap -
R754-m1
PPMGYGPrMQQPSNQ
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • DNA repair, induced
  • cell cycle regulation
  • transcription, induced
Treatment
  • siRNA
p300 (human) PPMGYGPrMQQPSNQ R754-m1
p300 (mouse) PPMGYGPRMQQASGQ R755
p300 (rat) PPMGYGPRMQQTSGQ R755
S831-p
QPALHQNsPsPVPSR
Upstream
1 0
Regulatory protein:
  • AML1 (human)
p300 (human) QPALHQNsPsPVPSR S831-p
p300 (mouse) PQQAHQNSPSPVPSR S831
p300 (rat) PQQAHQNSPSPVPSR S831
S833-p
ALHQNsPsPVPSRtP
Upstream
1 0
Regulatory protein:
  • AML1 (human)
p300 (human) ALHQNsPsPVPSRtP S833-p
p300 (mouse) QAHQNSPSPVPSRTP S833
p300 (rat) QAHQNSPSPVPSRTP S833
T839-p
PsPVPSRtPtPHHtP
Upstream
1 0
Regulatory protein:
  • AML1 (human)
p300 (human) PsPVPSRtPtPHHtP T839-p
p300 (mouse) PSPVPSRTPTPHHTP T839
p300 (rat) PSPVPSRTPTPHHTP T839
T841-p
PVPSRtPtPHHtPPS
Upstream
1 0
Regulatory protein:
  • AML1 (human)
p300 (human) PVPSRtPtPHHtPPS T841-p
p300 (mouse) PVPSRTPTPHHTPPS T841
p300 (rat) PVPSRTPTPHHTPPS T841
T845-p
RtPtPHHtPPSIGAQ
Upstream
1 0
Regulatory protein:
  • AML1 (human)
p300 (human) RtPtPHHtPPSIGAQ T845-p
p300 (mouse) RTPTPHHTPPSIGNQ T845
p300 (rat) RTPTPHHTPPSIGTQ T845
T885-p
LHPPPRQtPtPPTtQ
Upstream
1 2
Regulatory protein:
  • AML1 (human)
p300 (human) LHPPPRQtPtPPTtQ T885-p
p300 (mouse) LHPSSRQTPtPPTHL T885
p300 (rat) LRPPSRQTPTPPTHL T885
T887-p
PPPRQtPtPPTtQLP
Upstream
1 4
Regulatory protein:
  • AML1 (human)
p300 (human) PPPRQtPtPPTtQLP T887-p
p300 (mouse) PSSRQTPtPPTHLPP T887-p
p300 (rat) PPSRQTPTPPTHLPP T887
T891-p
QtPtPPTtQLPQQVQ
0 2
p300 (human) QtPtPPTtQLPQQVQ T891-p
p300 (mouse) gap -
p300 (rat) gap -
S900
LPQQVQPSLPAAPSA
0 1
p300 (human) LPQQVQPSLPAAPSA S900
p300 (mouse) LPPQVQPsLPAAPSA S899-p
p300 (rat) LPPQVQPSLPVPPAD S899
T938-p
LLPPQPAtPLSQPAV
Upstream
1 0
Kinase, in vitro:
  • ERK2 (human)
p300 (human) LLPPQPAtPLSQPAV T938-p
p300 (mouse) LLPPQPSTPLSQPAV T937
p300 (rat) LLPPQPPTPLSQPAV T936
K970-ac
NSQAIAEkQPSQEVk
1 0
p300 (human) NSQAIAEkQPSQEVk K970-ac
p300 (mouse) NSQTIPEKQPSQEVK K969
p300 (rat) NSQTIPEKQPSQEVK K968
K977-ac
kQPSQEVkMEAkMEV
Upstream
0 3
Treatment
  • MS275
p300 (human) kQPSQEVkMEAkMEV K977-ac
p300 (mouse) KQPSQEVKMESKMEV K976
p300 (rat) KQPSQEVKMEVKMDV K975
K981-ac
QEVkMEAkMEVDQPE
Upstream
1 3
Treatment
  • vorinostat
p300 (human) QEVkMEAkMEVDQPE K981-ac
p300 (mouse) QEVKMESKMEVDKPE K980
p300 (rat) QEVKMEVKMDVDQPE K979
K1001-ac
PEDISESkVEDCkME
1 7
p300 (human) PEDISESkVEDCkME K1001-ac
p300 (mouse) PEDTKEAKGEDVKVE K1000
p300 (rat) PDDTKEAKAEDGkVE K999
K1006-ac
ESkVEDCkMESTETE
0 2
p300 (human) ESkVEDCkMESTETE K1006-ac
p300 (mouse) EAKGEDVKVEPTEME K1005
p300 (rat) EAKAEDGkVEPTETE K1004-ac
K1020-ac
EERSTELkTEIkEEE
Upstream
Downstream
2 1
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • nicotinamide
  • trichostatin_A
p300 (human) EERSTELkTEIkEEE K1020-ac
p300 (mouse) EERGPELKTDGKEEE K1019
p300 (rat) EERGPELKTEVKEEE K1018
K1020-sm
EERSTELkTEIkEEE
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, inhibited
p300 (human) EERSTELkTEIkEEE K1020-sm
p300 (mouse) EERGPELKTDGKEEE K1019
p300 (rat) EERGPELKTEVKEEE K1018
K1024-ac
TELkTEIkEEEDQPS
Upstream
Downstream
1 1
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • nicotinamide
  • trichostatin_A
p300 (human) TELkTEIkEEEDQPS K1024-ac
p300 (mouse) PELKTDGKEEEEQPS K1023
p300 (rat) PELKTEVKEEEDQPS K1022
K1024-sm
TELkTEIkEEEDQPS
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, inhibited
p300 (human) TELkTEIkEEEDQPS K1024-sm
p300 (mouse) PELKTDGKEEEEQPS K1023
p300 (rat) PELKTEVKEEEDQPS K1022
S1037-p
PSTSATQssPAPGQs
0 5
p300 (human) PSTSATQssPAPGQs S1037-p
p300 (mouse) PSTSATQssPAPGQS S1036-p
p300 (rat) PSTSAAQSsPAPGQS S1035
S1038-p
STSATQssPAPGQsk
Upstream
Downstream
1 27
Effects on Modified Protein
  • acetylation
  • protein degradation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell cycle regulation
  • cell growth, induced
  • cell motility, induced
  • chromatin organization, altered
  • transcription, inhibited
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
  • ERK1 (human)
  • ERK2 (human)
view more >
Treatment
  • cycloheximide
  • metformin
  • nocodazole
  • seliciclib
  • siRNA
  • U0126
view more >
p300 (human) STSATQssPAPGQsk S1038-p
p300 (mouse) STSATQssPAPGQSK S1037-p
p300 (rat) STSAAQSsPAPGQSK S1036-p
S1044-p
ssPAPGQskkkIFKP
0 2
p300 (human) ssPAPGQskkkIFKP S1044-p
p300 (mouse) ssPAPGQSKKKIFKP S1043
p300 (rat) SsPAPGQSKKKIFKP S1042
K1045-ac
sPAPGQskkkIFKPE
1 0
p300 (human) sPAPGQskkkIFKPE K1045-ac
p300 (mouse) sPAPGQSKKKIFKPE K1044
p300 (rat) sPAPGQSKKKIFKPE K1043
K1046-ac
PAPGQskkkIFKPEE
1 0
p300 (human) PAPGQskkkIFKPEE K1046-ac
p300 (mouse) PAPGQSKKKIFKPEE K1045
p300 (rat) PAPGQSKKKIFKPEE K1044
K1047-ac
APGQskkkIFKPEEL
1 0
p300 (human) APGQskkkIFKPEEL K1047-ac
p300 (mouse) APGQSKKKIFKPEEL K1046
p300 (rat) APGQSKKKIFKPEEL K1045
Y1089-p
QLLGIPDyFDIVkSP
0 1
p300 (human) QLLGIPDyFDIVkSP Y1089-p
p300 (mouse) QLLGIPDYFDIVKSP Y1088
p300 (rat) QLLGIPDYFDIVKSP Y1087
K1094-ac
PDyFDIVkSPMDLST
1 0
p300 (human) PDyFDIVkSPMDLST K1094-ac
p300 (mouse) PDYFDIVKSPMDLST K1093
p300 (rat) PDYFDIVKSPMDLST K1092
K1103-ac
PMDLSTIkRkLDTGQ
0 1
p300 (human) PMDLSTIkRkLDTGQ K1103-ac
p300 (mouse) PMDLSTIKRKLDTGQ K1102
p300 (rat) PMDLSTIKRKLDTGQ K1101
K1105-ac
DLSTIkRkLDTGQYQ
1 0
p300 (human) DLSTIkRkLDTGQYQ K1105-ac
p300 (mouse) DLSTIKRKLDTGQYQ K1104
p300 (rat) DLSTIKRKLDTGQYQ K1103
T1135-p
AWLYNRKtSRVYKYC
0 1
p300 (human) AWLYNRKtSRVYKYC T1135-p
p300 (mouse) AWLYNRKTSRVYKYC T1134
p300 (rat) AWLYNRKTSRVYKYC T1133
K1144-ac
RVYKYCSkLSEVFEQ
1 0
p300 (human) RVYKYCSkLSEVFEQ K1144-ac
p300 (mouse) RVYKYCSKLSEVFEQ K1143
p300 (rat) RVYKYCSKLSEVFEQ K1142
K1167-ac
LGYCCGRkLEFSPQT
1 4
p300 (human) LGYCCGRkLEFSPQT K1167-ac
p300 (mouse) LGYCCGRKLEFSPQT K1166
p300 (rat) LGYCCGRKLEFSPQT K1165
K1167-ub
LGYCCGRkLEFSPQT
0 1
p300 (human) LGYCCGRkLEFSPQT K1167-ub
p300 (mouse) LGYCCGRKLEFSPQT K1166
p300 (rat) LGYCCGRKLEFSPQT K1165
K1180-ac
QTLCCYGkQLCTIPR
Upstream
1 70
Treatment
  • MS275
p300 (human) QTLCCYGkQLCTIPR K1180-ac
p300 (mouse) QTLCCYGKQLCTIPR K1179
p300 (rat) QTLCCYGKQLCTIPR K1178
K1203-ac
NRYHFCEkCFNEIQG
1 1
p300 (human) NRYHFCEkCFNEIQG K1203-ac
p300 (mouse) NRYHFCEKCFNEIQG K1202
p300 (rat) NRYHFCEKCFNEIQG K1201
K1228-ac
QPQTTINkEQFSKRK
1 0
p300 (human) QPQTTINkEQFSKRK K1228-ac
p300 (mouse) QPQTTINKEQFSKRK K1227
p300 (rat) QPQTTINKEQFSKRK K1226
S1295-p
FSAKRLPstRLGTFL
0 1
p300 (human) FSAKRLPstRLGTFL S1295-p
p300 (mouse) LSAKRLPSTRLGTFL S1294
p300 (rat) FSAKRLPSTRLGTFL S1293
T1296-p
SAKRLPstRLGTFLE
0 1
p300 (human) SAKRLPstRLGTFLE T1296-p
p300 (mouse) SAKRLPSTRLGTFLE T1295
p300 (rat) SAKRLPSTRLGTFLE T1294
K1331-ac
RVVHASDkTVEVkPG
1 0
p300 (human) RVVHASDkTVEVkPG K1331-ac
p300 (mouse) RVVHASDKTVEVKPG K1330
p300 (rat) RVVHASDKTVEVKPG K1329
K1336-ac
SDkTVEVkPGMkARF
3 1
p300 (human) SDkTVEVkPGMkARF K1336-ac
p300 (mouse) SDKTVEVKPGMKARF K1335
p300 (rat) SDKTVEVKPGMKARF K1334
K1340-ac
VEVkPGMkARFVDSG
1 4
p300 (human) VEVkPGMkARFVDSG K1340-ac
p300 (mouse) VEVKPGMKARFVDSG K1339
p300 (rat) VEVKPGMKARFVDSG K1338
K1340-ub
VEVkPGMkARFVDSG
0 1
p300 (human) VEVkPGMkARFVDSG K1340-ub
p300 (mouse) VEVKPGMKARFVDSG K1339
p300 (rat) VEVKPGMKARFVDSG K1338
Y1355-p
EMAESFPyRTKALFA
0 2
p300 (human) EMAESFPyRTKALFA Y1355-p
p300 (mouse) EMAESFPYRTKALFA Y1354
p300 (rat) EMAESFPyRTKALFA Y1353-p
Y1394
PPNQRRVYISYLDSV
0 1
p300 (human) PPNQRRVYISYLDSV Y1394
p300 (mouse) PPNQRRVyIsyLDsV Y1393-p
p300 (rat) PPNQRRVYISYLDSV Y1392
S1396
NQRRVYISYLDSVHF
0 1
p300 (human) NQRRVYISYLDSVHF S1396
p300 (mouse) NQRRVyIsyLDsVHF S1395-p
p300 (rat) NQRRVYISYLDSVHF S1394
Y1397
QRRVYISYLDSVHFF
0 1
p300 (human) QRRVYISYLDSVHFF Y1397
p300 (mouse) QRRVyIsyLDsVHFF Y1396-p
p300 (rat) QRRVYISYLDSVHFF Y1395
S1400
VYISYLDSVHFFRPK
0 1
p300 (human) VYISYLDSVHFFRPK S1400
p300 (mouse) VyIsyLDsVHFFRPK S1399-p
p300 (rat) VYISYLDSVHFFRPK S1398
Y1414
KCLRTAVYHEILIGY
0 1
p300 (human) KCLRTAVYHEILIGY Y1414
p300 (mouse) KCLRTAVyHEILIGy Y1413-p
p300 (rat) KCLRTAVYHEILIGY Y1412
Y1421
YHEILIGYLEYVKkL
0 1
p300 (human) YHEILIGYLEYVKkL Y1421
p300 (mouse) yHEILIGyLEyVKKL Y1420-p
p300 (rat) YHEILIGYLEYVKKL Y1419
Y1424
ILIGYLEYVKkLGYT
0 1
p300 (human) ILIGYLEYVKkLGYT Y1424
p300 (mouse) ILIGyLEyVKKLGYT Y1423-p
p300 (rat) ILIGYLEYVKKLGYT Y1422
K1427-ac
GYLEYVKkLGYTTGH
1 0
p300 (human) GYLEYVKkLGYTTGH K1427-ac
p300 (mouse) GyLEyVKKLGYTTGH K1426
p300 (rat) GYLEYVKKLGYTTGH K1425
Y1446-p
PPSEGDDyIFHCHPP
0 1
p300 (human) PPSEGDDyIFHCHPP Y1446-p
p300 (mouse) PPSEGDDYIFHCHPP Y1445
p300 (rat) PPSEGDDYIFHCHPP Y1444
K1473-ac
WYKKMLDkAVSERIV
2 0
p300 (human) WYKKMLDkAVSERIV K1473-ac
p300 (mouse) WYKKMLDKAVSERIV K1472
p300 (rat) WYKKMLDKAVSERIV K1471
K1499-ac
EDRLTSAkELPYFEG
Upstream
5 13
p300 (human)
K1499-ac
p300 (mouse)
K1498-ac
Regulatory protein:
  • OGT (human)
Treatment
  • MS275
  • vorinostat
p300 (human) EDRLTSAkELPYFEG K1499-ac
p300 (mouse) EDRLTSAkELPYFEG K1498-ac
p300 (rat) EDRLTSAkELPYFEG K1497-ac
K1518-ac
NVLEESIkELEQEEE
1 0
p300 (human) NVLEESIkELEQEEE K1518-ac
p300 (mouse) NVLEESIKELEQEEE K1517
p300 (rat) NVLEESIKELEQEEE K1516
K1528-ac
EQEEEERkREENtsN
1 0
p300 (human) EQEEEERkREENtsN K1528-ac
p300 (mouse) EQEEEERKREENTSN K1527
p300 (rat) EQEEEERKREENTSN K1526
T1533-p
ERkREENtsNESTDV
0 1
p300 (human) ERkREENtsNESTDV T1533-p
p300 (mouse) ERKREENTSNESTDV T1532
p300 (rat) ERKREENTSNESTDV T1531
S1534-p
RkREENtsNESTDVT
0 1
p300 (human) RkREENtsNESTDVT S1534-p
p300 (mouse) RKREENTSNESTDVT S1533
p300 (rat) RKREENTSNESTDVT S1532
K1542-ac
NESTDVTkGDSkNAk
Upstream
3 253
Treatment
  • MS275
  • vorinostat
p300 (human) NESTDVTkGDSkNAk K1542-ac
p300 (mouse) NESTDVTkGDSkNAk K1541-ac
p300 (rat) NESTDVTkGDSkNAK K1540-ac
K1546-ac
DVTkGDSkNAkkkNN
Upstream
3 275
Treatment
  • MS275
  • vorinostat
p300 (human) DVTkGDSkNAkkkNN K1546-ac
p300 (mouse) DVTkGDSkNAkkkNN K1545-ac
p300 (rat) DVTkGDSkNAKKKNN K1544-ac
K1549-ac
kGDSkNAkkkNNkkT
Upstream
3 218
Treatment
  • vorinostat
p300 (human) kGDSkNAkkkNNkkT K1549-ac
p300 (mouse) kGDSkNAkkkNNkkT K1548-ac
p300 (rat) kGDSkNAKKKNNKKT K1547
K1550-ac
GDSkNAkkkNNkkTS
Upstream
3 174
Treatment
  • vorinostat
p300 (human) GDSkNAkkkNNkkTS K1550-ac
p300 (mouse) GDSkNAkkkNNkkTS K1549-ac
p300 (rat) GDSkNAKKKNNKKTS K1548
K1551-ac
DSkNAkkkNNkkTSk
3 55
p300 (human) DSkNAkkkNNkkTSk K1551-ac
p300 (mouse) DSkNAkkkNNkkTSk K1550-ac
p300 (rat) DSkNAKKKNNKKTSk K1549
K1554-ac
NAkkkNNkkTSkNkS
Upstream
3 207
Treatment
  • MS275
  • vorinostat
p300 (human) NAkkkNNkkTSkNkS K1554-ac
p300 (mouse) NAkkkNNkkTSkNkS K1553-ac
p300 (rat) NAKKKNNKKTSkNkS K1552
K1555-ac
AkkkNNkkTSkNkSS
Upstream
3 213
Treatment
  • MS275
  • vorinostat
p300 (human) AkkkNNkkTSkNkSS K1555-ac
p300 (mouse) AkkkNNkkTSkNkSS K1554-ac
p300 (rat) AKKKNNKKTSkNkSS K1553
K1558-ac
kNNkkTSkNkSSLSR
Upstream
4 216
Treatment
  • MS275
  • vorinostat
p300 (human) kNNkkTSkNkSSLSR K1558-ac
p300 (mouse) kNNkkTSkNkSSLSR K1557-ac
p300 (rat) KNNKKTSkNkSSLSR K1556-ac
K1560-ac
NkkTSkNkSSLSRGN
Upstream
3 113
Treatment
  • MS275
  • vorinostat
p300 (human) NkkTSkNkSSLSRGN K1560-ac
p300 (mouse) NkkTSkNkSSLSRGN K1559-ac
p300 (rat) NKKTSkNkSSLSRGN K1558-ac
K1568-ac
SSLSRGNkkkPGMPN
1 3
p300 (human) SSLSRGNkkkPGMPN K1568-ac
p300 (mouse) SSLSRGNKKKPGMPN K1567
p300 (rat) SSLSRGNKKkPGVPN K1566
K1569-ac
SLSRGNkkkPGMPNV
1 3
p300 (human) SLSRGNkkkPGMPNV K1569-ac
p300 (mouse) SLSRGNKKKPGMPNV K1568
p300 (rat) SLSRGNKKkPGVPNV K1567
K1570-ac
LSRGNkkkPGMPNVs
1 2
p300 (human) LSRGNkkkPGMPNVs K1570-ac
p300 (mouse) LSRGNKKKPGMPNVS K1569
p300 (rat) LSRGNKKkPGVPNVS K1568-ac
S1577-p
kPGMPNVsNDLsQkL
Upstream
0 1
Regulatory protein:
  • PLK1 (human)
p300 (human) kPGMPNVsNDLsQkL S1577-p
p300 (mouse) KPGMPNVSNDLSQKL S1576
p300 (rat) kPGVPNVSNDLSQkL S1575
S1581-p
PNVsNDLsQkLYATM
Upstream
0 1
Regulatory protein:
  • PLK1 (human)
p300 (human) PNVsNDLsQkLYATM S1581-p
p300 (mouse) PNVSNDLSQKLYATM S1580
p300 (rat) PNVSNDLSQkLYATM S1579
K1583-ac
VsNDLsQkLYATMEk
Upstream
1 24
Treatment
  • MS275
  • vorinostat
p300 (human) VsNDLsQkLYATMEk K1583-ac
p300 (mouse) VSNDLSQKLYATMEk K1582
p300 (rat) VSNDLSQkLYATMEk K1581-ac
K1583-ub
VsNDLsQkLYATMEk
0 1
p300 (human) VsNDLsQkLYATMEk K1583-ub
p300 (mouse) VSNDLSQKLYATMEk K1582
p300 (rat) VSNDLSQKLYATMEk K1581
K1590-ac
kLYATMEkHKEVFFV
Upstream
1 11
Treatment
  • MS275
  • vorinostat
p300 (human) kLYATMEkHKEVFFV K1590-ac
p300 (mouse) KLYATMEkHKEVFFV K1589-ac
p300 (rat) kLYATMEkHKEVFFV K1588-ac
K1590-ub
kLYATMEkHKEVFFV
0 1
p300 (human) kLYATMEkHKEVFFV K1590-ub
p300 (mouse) KLYATMEKHKEVFFV K1589
p300 (rat) kLYATMEKHKEVFFV K1588
K1637-ac
FLTLARDkHLEFSSL
2 0
p300 (human) FLTLARDkHLEFSSL K1637-ac
p300 (mouse) FLTLARDKHLEFSSL K1636
p300 (rat) FLTLARDKHLEFSSL K1635
K1637-ub
FLTLARDkHLEFSSL
0 1
p300 (human) FLTLARDkHLEFSSL K1637-ub
p300 (mouse) FLTLARDKHLEFSSL K1636
p300 (rat) FLTLARDKHLEFSSL K1635
K1674-ac
VYTCNECkHHVETRW
Upstream
1 17
Treatment
  • MS275
  • vorinostat
p300 (human) VYTCNECkHHVETRW K1674-ac
p300 (mouse) VYTCNECKHHVETRW K1673
p300 (rat) VYTCNECkHHVETRW K1672-ac
K1699-ac
CITCYNTkNHDHkME
1 0
p300 (human) CITCYNTkNHDHkME K1699-ac
p300 (mouse) CITCYNTKNHDHKME K1698
p300 (rat) CITCYNTKNHDHkME K1697
K1704-ac
NTkNHDHkMEkLGLG
1 9
p300 (human) NTkNHDHkMEkLGLG K1704-ac
p300 (mouse) NTKNHDHKMEKLGLG K1703
p300 (rat) NTKNHDHkMEkLGLG K1702-ac
K1707-ac
NHDHkMEkLGLGLDD
1 6
p300 (human) NHDHkMEkLGLGLDD K1707-ac
p300 (mouse) NHDHKMEKLGLGLDD K1706
p300 (rat) NHDHkMEkLGLGLDD K1705-ac
S1726-p
QQAAATQsPGDSRRL
0 9
p300 (human) QQAAATQsPGDSRRL S1726-p
p300 (mouse) QQAAATQsPGDSRRL S1725-p
p300 (rat) QQAAATQSPGDSRRL S1724
S1734
PGDSRRLSIQRCIQS
1 0
p300 (human) PGDSRRLSIQRCIQS S1734
p300 (mouse) PGDSRRLsIQRCIQS S1733-p
p300 (rat) PGDSRRLSIQRCIQS S1732
K1760-ac
CSLPSCQkMkRVVQH
1 20
p300 (human) CSLPSCQkMkRVVQH K1760-ac
p300 (mouse) CSLPSCQkMKRVVQH K1759-ac
p300 (rat) CSLPSCQKMKRVVQH K1758
K1762-ac
LPSCQkMkRVVQHTk
1 6
p300 (human) LPSCQkMkRVVQHTk K1762-ac
p300 (mouse) LPSCQkMKRVVQHTK K1761
p300 (rat) LPSCQKMKRVVQHTk K1760
K1769-ac
kRVVQHTkGCkRkTN
1 16
p300 (human) kRVVQHTkGCkRkTN K1769-ac
p300 (mouse) KRVVQHTKGCKRKTN K1768
p300 (rat) KRVVQHTkGCkRKTN K1767-ac
K1772-ac
VQHTkGCkRkTNGGC
1 16
p300 (human) VQHTkGCkRkTNGGC K1772-ac
p300 (mouse) VQHTKGCKRKTNGGC K1771
p300 (rat) VQHTkGCkRKTNGGC K1770-ac
K1774-ac
HTkGCkRkTNGGCPI
1 0
p300 (human) HTkGCkRkTNGGCPI K1774-ac
p300 (mouse) HTKGCKRKTNGGCPI K1773
p300 (rat) HTkGCkRKTNGGCPI K1772
K1783-ac
NGGCPICkQLIALCC
1 1
p300 (human) NGGCPICkQLIALCC K1783-ac
p300 (mouse) NGGCPICKQLIALCC K1782
p300 (rat) NGGCPICKQLIALCC K1781
K1794-ac
ALCCYHAkHCQENkC
1 3
p300 (human) ALCCYHAkHCQENkC K1794-ac
p300 (mouse) ALCCYHAKHCQENKC K1793
p300 (rat) ALCCYHAKHCQENKC K1792
K1800-ac
AkHCQENkCPVPFCL
1 8
p300 (human) AkHCQENkCPVPFCL K1800-ac
p300 (mouse) AKHCQENKCPVPFCL K1799
p300 (rat) AKHCQENKCPVPFCL K1798
K1810-ac
VPFCLNIkQkLRQQQ
1 0
p300 (human) VPFCLNIkQkLRQQQ K1810-ac
p300 (mouse) VPFCLNIKQKLRQQQ K1809
p300 (rat) VPFCLNIKQKLRQQQ K1808
K1812-ac
FCLNIkQkLRQQQLQ
1 0
p300 (human) FCLNIkQkLRQQQLQ K1812-ac
p300 (mouse) FCLNIKQKLRQQQLQ K1811
p300 (rat) FCLNIKQKLRQQQLQ K1810
S1834-p
MLRRRMAsMQRTGVV
Upstream
Downstream
10 0
Effects on Modified Protein
  • acetylation
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
Regulatory protein:
  • Akt1 (human)
  • p70S6K (human)
Treatment
  • EGF
  • light
  • LY294002
  • MK-2206
  • rapamycin
  • SB203580
  • SH-5
  • siRNA
  • thrombin
  • TNF
  • UV
  • vorinostat
view more >
p300 (human) MLRRRMAsMQRTGVV S1834-p
p300 (mouse) MLRRRMAsMQRTGVA S1833-p
p300 (rat) MLRRRMASMQRTGVA S1832
T1857-p
PTPATPTtPtGQQPT
0 1
p300 (human) PTPATPTtPtGQQPT T1857-p
p300 (mouse) PTPATPTTPTGQQPA T1856
p300 (rat) PTPATPTTPTGQQPA T1855
T1859-p
PATPTtPtGQQPTTP
0 1
p300 (human) PATPTtPtGQQPTTP T1859-p
p300 (mouse) PATPTTPTGQQPATP T1858
p300 (rat) PATPTTPTGQQPATP T1857
S1897-p
TQAAGPVsQGkAAGQ
0 3
p300 (human) TQAAGPVsQGkAAGQ S1897-p
p300 (mouse) TQTTGPVSQGKAPGQ S1898
p300 (rat) TQTAGPVSQGKAAGQ S1897
K1900-ac
AGPVsQGkAAGQVtP
0 1
p300 (human) AGPVsQGkAAGQVtP K1900-ac
p300 (mouse) TGPVSQGKAPGQVTP K1901
p300 (rat) AGPVSQGKAAGQVTP K1900
T1906-p
GkAAGQVtPPtPPQT
0 2
p300 (human) GkAAGQVtPPtPPQT T1906-p
p300 (mouse) GKAPGQVTPPTPPQT T1907
p300 (rat) GKAAGQVTPPTPPQT T1906
T1909-p
AGQVtPPtPPQTAQP
0 2
p300 (human) AGQVtPPtPPQTAQP T1909-p
p300 (mouse) PGQVTPPTPPQTAQA T1910
p300 (rat) AGQVTPPTPPQTAQP T1909
T1960-p
QHQMPPMtPMAPMGM
Upstream
1 0
Kinase, in vitro:
  • ERK2 (human)
p300 (human) QHQMPPMtPMAPMGM T1960-p
p300 (mouse) QHQMPQMSPMAPMGM S1961
p300 (rat) RPIQHQMAPMAPMGM A1957
S2039-p
GLGQVGIsPLKPGTV
Upstream
Downstream
1 0
Effects on Modified Protein
  • acetylation
  • protein degradation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell cycle regulation
  • cell growth, induced
  • cell motility, induced
  • chromatin organization, altered
  • transcription, inhibited
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
  • ERK1 (human)
  • ERK2 (human)
view more >
Treatment
  • cycloheximide
  • nocodazole
  • seliciclib
  • siRNA
  • U0126
view more >
p300 (human) GLGQVGIsPLKPGTV S2039-p
p300 (mouse) GLGQVGVSPLKPGTV S2040
p300 (rat) GLGQVGVSPLKPGTV S2036
R2059-m1
QNLLRTLrSPSSPLQ
0 2
p300 (human) QNLLRTLrSPSSPLQ R2059-m1
p300 (mouse) QNLLRTLRSPSSPLQ R2060
p300 (rat) QNLLRTLRSPSSPLQ R2056
R2059-m2
QNLLRTLrSPSSPLQ
0 2
p300 (human) QNLLRTLrSPSSPLQ R2059-m2
p300 (mouse) QNLLRTLrSPSSPLQ R2060-m2
p300 (rat) QNLLRTLRSPSSPLQ R2056
K2086-ac
QLLAAFIkQRAAkYA
1 0
p300 (human) QLLAAFIkQRAAkYA K2086-ac
p300 (mouse) QLLAAFIKQRAAKYA K2087
p300 (rat) QLLAAFIKQRAAKYA K2083
K2091-ac
FIkQRAAkYANSNPQ
1 0
p300 (human) FIkQRAAkYANSNPQ K2091-ac
p300 (mouse) FIKQRAAKYANPNPQ K2092
p300 (rat) FIKQRAAKYANSNPQ K2088
R2142-me
PMQAGVQrAGLPQQQ
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, induced
Regulatory protein:
  • PADI4 (human)
p300 (human) PMQAGVQrAGLPQQQ R2142-me
p300 (mouse) PLQAGVQRAGLPQQQ R2143
p300 (rat) PMQAGVQRAGLPQQQ R2139
Y2219-p
QQPQGVGyPPQQQQr
0 1
p300 (human) QQPQGVGyPPQQQQr Y2219-p
p300 (mouse) QQPQGIGYPPQQQQQ Y2214
p300 (rat) QQPQGIGYPPQQQQQ Y2212
R2226-m1
yPPQQQQrMQHHMQQ
0 1
p300 (human) yPPQQQQrMQHHMQQ R2226-m1
p300 (mouse) PQQQQQQRMQHHMQQ R2223
p300 (rat) QQQQQQQRMQHHMQQ R2224
S2271
LLQQQMGSPVQPNPM
0 1
p300 (human) LLQQQMGSPVQPNPM S2271
p300 (mouse) LLQQQMGsPAQPNPM S2268-p
p300 (rat) LLQQQMGSPAQPNPM S2269
S2279-p
PVQPNPMsPQQHMLP
Upstream
Downstream
4 1
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK2 (human)
  • HIPK2 (human)
Regulatory protein:
  • C/EBP-beta (human)
  • HIPK2 (human)
Treatment
  • celastrol
  • EGF
  • U0126
view more >
p300 (human) PVQPNPMsPQQHMLP S2279-p
p300 (mouse) PAQPNPMsPQQHMLP S2276-p
p300 (rat) PAQPNPMSPQQHMLP S2277
S2291
MLPNQAQSPHLQGQQ
0 1
p300 (human) MLPNQAQSPHLQGQQ S2291
p300 (mouse) MLPNQAQsPHLQGQQ S2288-p
p300 (rat) MLPNQAQSPHLQGQQ S2289
S2309-p
SLSNQVRsPQPVPsP
0 7
p300 (human) SLSNQVRsPQPVPsP S2309-p
p300 (mouse) SLSNQVRsPQPVPsP S2306-p
p300 (rat) SLSNQVRSPQPVPSP S2307
S2315-p
RsPQPVPsPrPQsQP
Upstream
Downstream
2 11
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK2 (human)
Treatment
  • EGF
  • U0126
p300 (human) RsPQPVPsPrPQsQP S2315-p
p300 (mouse) RsPQPVPsPRPQsQP S2312-p
p300 (rat) RSPQPVPSPRPQSQP S2313
R2317-m1
PQPVPsPrPQsQPPH
0 1
p300 (human) PQPVPsPrPQsQPPH R2317-m1
p300 (mouse) PQPVPsPRPQsQPPH R2314
p300 (rat) PQPVPSPRPQSQPPH R2315
S2320-p
VPsPrPQsQPPHssP
0 4
p300 (human) VPsPrPQsQPPHssP S2320-p
p300 (mouse) VPsPRPQsQPPHssP S2317-p
p300 (rat) VPSPRPQSQPPHSSP S2318
S2325-p
PQsQPPHssPsPrMQ
0 4
p300 (human) PQsQPPHssPsPrMQ S2325-p
p300 (mouse) PQsQPPHssPsPRMQ S2322-p
p300 (rat) PQSQPPHSSPSPRMQ S2323
S2326-p
QsQPPHssPsPrMQP
0 3
p300 (human) QsQPPHssPsPrMQP S2326-p
p300 (mouse) QsQPPHssPsPRMQP S2323-p
p300 (rat) QSQPPHSSPSPRMQP S2324
S2328-p
QPPHssPsPrMQPQP
0 6
p300 (human) QPPHssPsPrMQPQP S2328-p
p300 (mouse) QPPHssPsPRMQPQP S2325-p
p300 (rat) QPPHSSPSPRMQPQP S2326
R2330-m1
PHssPsPrMQPQPSP
0 1
p300 (human) PHssPsPrMQPQPSP R2330-m1
p300 (mouse) PHssPsPRMQPQPSP R2327
p300 (rat) PHSSPSPRMQPQPSP R2328
S2366-p
MEQGHFAsPDQNSML
Upstream
Downstream
2 0
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK2 (human)
Treatment
  • EGF
  • U0126
p300 (human) MEQGHFAsPDQNSML S2366-p
p300 (mouse) MEQGHFAsPDQNSML S2364-p
p300 (rat) MEQGHFASPDQNSML S2365